Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

ZINC SULFATE

ZINC SULFATE

Standard Dose
EQ 10MG BASE/10ML (EQ 1MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ZINC SULFATE is listed in Drugs@FDA under application 219585 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ZINC SULFATE Form and strength SOLUTION;INTRAVENOUS - EQ 10MG BASE/10ML (EQ 1MG BASE/ML) Sponsor ASPIRO Submission history Latest submission status date: 2025-05-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZINC SULFATE is listed in Drugs@FDA under application 219585 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ZINC SULFATE Form and strength SOLUTION;INTRAVENOUS - EQ 10MG BASE/10ML (EQ 1MG BASE/ML) Sponsor ASPIRO Submission history Latest submission status date: 2025-05-01 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.